...
首页> 外文期刊>Molecular Carcinogenesis >Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma
【24h】

Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma

机译:免疫相关的LNCRNA识别肾透明细胞癌的新型预后亚型

获取原文
获取原文并翻译 | 示例
           

摘要

Kidney Renal Clear Cell Carcinoma (KIRC) is a significant cause of cancer‐related deaths. Here, we aim to identify the LncRNAs associated with the immune system and characterise their clinical utility in KIRC. A total of 504 patients’ data was used from TCGA‐GDC. In silico correlation analysis identified 143 LncRNAs associated with immune‐related genes ( r ??0.7, P ??0.05). K‐means consensus method clustered KIRC samples in three immune clusters, namely cluster C1, C2, and C3 based on the expression of 143 immune‐related LncRNAs. Kaplan‐Meier analysis showed that C3 patients survived significantly worse than the other two clusters ( P ??0.0001). A comparison of TCGA miRNA, mRNA cluster with immune cluster showed the independence and robustness of immune clusters (HR?=?2.02 and P ?=?2.12?×?10 ?8 ). The GSEA and CIBERSORT analysis showed high enrichment of poorly activated T‐cells in C3 patients. To define LncRNA immune prognostic signature, we randomly divided the TCGA sample into discovery and validation sets. By utilising multivariate Cox regression analysis, we identified and validated a seven LncRNA immune prognostic signature score (LIPS score) (HR?=?1.43 and P ?=?2.73?×?10 ?6 ) in KIRC. Comparison of LIPS score with all the clinical factors validated its independence and superiority in KIRC prognosis. In summary, we identified LncRNAs associated with the immune system and showed the presence of prognostic subtypes of KIRC patients based on immune‐related LncRNA expression. We also identified a novel immune LncRNA based gene‐signature for KIRC patients’ prognostication.
机译:肾肾透明细胞癌(KIRC)是癌症相关死亡的重要原因。在这里,我们的目标是鉴定与免疫系统相关的LNCRNA,并在kirc中表征其临床效用。从TCGA-GDC使用共有504名患者的数据。在硅相关性分析中,鉴定了与免疫相关基因相关的143个LNCRNA(R→&β0.7,p≤0.05)。 K-MeanseClease方法在三种免疫簇中聚类KIRC样品,即基于143个免疫相关LNCRNA的表达的组簇C1,C2和C3。 Kaplan-Meier分析表明,C3患者的存活率比其他两个簇状显着差(P?& 0.0001)。 TCGA miRNA的比较,具有免疫聚类的mRNA簇显示了免疫簇的独立性和鲁棒性(HR?=?2.02和P?= 2.12?×10?8)。 GSEA和Cibersort分析表明C3患者中活化的T细胞的高浓缩。为了定义LNCRNA免疫预后签名,我们将TCGA样本随机分为发现和验证集。通过利用多元COX回归分析,我们鉴定并验证了七次LNCRNA免疫预后签名评分(HR?=?1.43和P?=?2.73?×10?6)。嘴唇评分与所有临床因素的比较验证了kirc预后的独立性和优越性。总之,我们鉴定了与免疫系统相关的LNCRNA,并显示基于免疫相关的LNCRNA表达的KIRC患者的预后亚型存在。我们还鉴定了一种新的免疫LNCRNA基因签名,用于KIRC患者预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号